Placebo Control
A review of key issues in pharmaceutical clinical trials
Showing posts with label
505(b)(2)
.
Show all posts
Showing posts with label
505(b)(2)
.
Show all posts
Saturday, March 18, 2017
The Streetlight Effect and 505(b)(2) approvals
›
It is a surprisingly common peril among analysts: we don’t have the data to answer the question we’re interested in, so we answer a related ...
›
Home
View web version
